That is the modis operandi of of the large investment houses, many of which were present on our recent conference call. This weeks action has allowed them to acquire starter positions for their clients at sub 10.00 prices. It's all good!
Would love to see some more upgrades and price targets close to $20, but why have they mostly failed to help us in the past? Which upgrades will actually help us get widespread attention? A really big bank?
catalysts of any sort in the past have been largely ineffective because all the big investors understood that the company was a long way from monetization... for the market it is all about monetization... which in turn means it is all about good clinical data leading to FDA approval... the big boys don't want their money sitting around too long doing nothing... so they wait, while the shorts and MM's play manipulating the price up and down... and in so doing providing nice price points for careful longs... but now playtime is almost over... so any catalyst at all at this stage of the game is more powerful... we are nearing the end of the developmental phase of this little biotech company... it is about to grow up...
Im not joking. Even after multiple warnings, anyone who was actually stupid enough to hold a short position over the weekend...well, they're TOAST! come Monday. As in FRIED ALIVE! (it won't be pretty) I think they've perpetrated what is commonly known of as a "SHART". Haa! - Better luck next time! LOL!